Cubist Systematic Strategies, LLC Neuro Pace Inc Transaction History

Cubist Systematic Strategies, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$6.38 - $15.33 $250,134 - $601,027	-39,206 Reduced 77.29%	11,519 $87,000
Q1 2024 May 15, 2024	BUY	$9.78 - $17.5 $384,451 - $687,925	39,310 Added 344.37%	50,725 $669,000
Q4 2023 Feb 14, 2024	BUY	$5.9 - $10.31 $67,348 - $117,688	11,415 New	11,415 $117,000
Q2 2022 Aug 15, 2022	BUY	$4.95 - $8.7 $3,133 - $5,507	633 Added 3516.67%	651 $3,000
Q1 2022 May 16, 2022	BUY	$7.06 - $11.57 $127 - $208	18 New	18 $0

21.3M

1.3K

100

Ticker NPCE
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,846,900
Market Cap $230M
Description
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.